311 related articles for article (PubMed ID: 23503652)
1. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
3. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
4. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.
Luo W; Yu WD; Ma Y; Chernov M; Trump DL; Johnson CS
Cancer Res; 2013 Apr; 73(7):2289-97. PubMed ID: 23358686
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
Lee M; Kim EJ; Jeon MJ
Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA regulates human vitamin D receptor.
Mohri T; Nakajima M; Takagi S; Komagata S; Yokoi T
Int J Cancer; 2009 Sep; 125(6):1328-33. PubMed ID: 19437538
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
10. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
11. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
13. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
14. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.
Chen L; Kong G; Zhang C; Dong H; Yang C; Song G; Guo C; Wang L; Yu H
Oncotarget; 2016 Apr; 7(15):20041-53. PubMed ID: 26942465
[TBL] [Abstract][Full Text] [Related]
16. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
17. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma.
He X; Liao S; Lu D; Zhang F; Sun Y; Wu Y
Int J Med Sci; 2021; 18(1):150-156. PubMed ID: 33390783
[No Abstract] [Full Text] [Related]
18. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
Nonn L; Peng L; Feldman D; Peehl DM
Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.
Wang WL; Chatterjee N; Chittur SV; Welsh J; Tenniswood MP
Mol Cancer; 2011 May; 10():58. PubMed ID: 21592394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]